Altria Group Inc Earnings - Q1 2026 Analysis & Highlights
Altria Group delivered strong Q1 2026 results driven by disciplined execution across smokeable and oral tobacco segments, with adjusted diluted EPS growth of 7.3%, while navigating a challenging macroeconomic environment and evolving regulatory landscape for e-vapor products.
Key Financial Results
Adjusted diluted EPS grew 7.3% in the first quarter.
Smokeable products segment generated strong income growth with adjusted OCI growing by 6.3%.
Oral tobacco products segment delivered over $400 million in total adjusted OCI in the first quarter.
Adjusted OCI margins in smokeable segment expanded to 65.1%, an increase of 0.7 percentage points.
Adjusted OCI margins in oral tobacco segment remained strong at 67.4%, down 1.8 percentage points from a year ago.
Equity earnings from ABI investment were $160 million, up 9.6% versus the prior year.
Business Segment Results
Smokeable segment net price realization was 6.3%, supporting strong financial performance.
Reported domestic cigarette volumes declined by 2.4%, with adjusted volumes declining by 4% when adjusted for trade inventory movements.
Marlboro expanded its share of the premium segment to 59.5%, up 0.1 share point versus the prior year and 0.2 share points sequentially.
Total PM USA retail share grew 0.1 share point sequentially and 0.4 share points versus a year ago.
Basic's retail share grew 0.5 share points sequentially and 2.4 share points year-over-year.
Reported shipment volume for the total on! portfolio grew nearly 18% to over 46 million cans in the first quarter.
On! and on! PLUS together represented 7.8% of the total oral tobacco category, down 0.8 share points year-over-year and up 0.2 share points sequentially.
On! PLUS was available in approximately 100,000 stores at the end of the first quarter, representing 85% of nicotine pouch category volume.
Nicotine pouch category grew 9.1 share points and now represents more than 58% of total oral tobacco.
Cigars reported shipment volume was down slightly by 0.2%, with Middleton continuing to outperform the large mass cigar industry.
Total segment reported shipment volume for oral tobacco products decreased 3.1% as growth in on! was more than offset by lower MST volumes.
Capital Allocation
Approximately $1.8 billion in dividends were paid in the first quarter.
4.5 million shares were repurchased for $280 million.
$720 million remained under the current share repurchase program, which expires at the end of the year.
Just over $1 billion of debt that matured in February was retired.
Total debt-to-EBITDA ratio as of March 31 was 1.9 times, in line with the company's target.
Industry Trends and Dynamics
Oral nicotine pouches drove an estimated 9.5% increase in total oral tobacco industry volume over the past six months.
Illicit flavored disposable e-vapor products remain prevalent, though after several years of rapid growth, signs of moderation began in the back half of 2025.
Increased enforcement activity and supply-related marketplace disruption have slowed demand for illicit e-vapor products, with these dynamics continuing into the first quarter.
At the end of March, there were approximately 20.5 million adult vapers, in line with the year-ago period.
The estimated number of disposable e-vapor consumers declined modestly over the same timeframe.
Domestic cigarette industry volumes declined by 5% when adjusted for trade inventory movements, marking the fourth consecutive quarter of sequential year-over-year moderation.
The trend in cigarette volumes was driven primarily by reduced cross-category movement between cigarettes and illicit flavored disposable e-vapor products.
Competitive Landscape
Marlboro strengthened its position in the premium segment and PM USA continued to execute its total portfolio strategy with discipline.
Helix delivered solid results in a highly competitive environment for nicotine pouches.
On! PLUS is the first and only product authorized under the FDA's pilot program, aimed at streamlining PMTA reviews for certain oral nicotine pouches.
On! PLUS features proprietary NICOSILK technology and is currently available in three flavors across two nicotine strengths.
Helix secured premium retail positioning in contracted stores representing approximately 90% of Helix volume through a new retail trade program.
Marlboro is still the aspirational brand in the cigarette category, allowing the company to remain competitive on a store-by-store basis while maintaining profitability.
Macroeconomic Environment
For consumers, the macroeconomic environment remains challenging, with elevated everyday expenses and higher gas prices continuing to weigh on discretionary income among more price-sensitive adult smokers.
Higher-than-normal tax refunds provided some short-term relief to consumers facing macroeconomic pressures.
Year-over-year discount segment retail share growth of 2.4 share points was driven primarily by the trade-down dynamic resulting from macroeconomic pressures.
Marlboro's overall retail share declined 1.4 share points versus the year-ago period, impacted by the trade-down dynamic.
Gas prices increased significantly at the end of the quarter, contributing to macroeconomic uncertainty.
Growth Opportunities and Strategies
On! PLUS expansion is supported by a new retail trade program focused on increasing visibility and securing incremental fixture space.
On! PLUS is prominently featured across key retail touchpoints with coordinated signage from curb to counter.
Marketing for on! PLUS highlights the product experience, including visuals that showcase the pouch itself, communicate comfort, and reinforce its positioning as the softest pouch on the planet.
Marketing initiatives include in-person events, brand partnerships, paid social media, and streaming audio aimed at increasing awareness, driving trial, and strengthening on! brand equity.
The FDA is reviewing applications for on! PLUS Mint, Wintergreen and Tobacco in 12-milligram strengths under its pilot program, with six additional flavor varieties submitted across three nicotine strengths.
Cowboy Cut will expand distribution later in the second quarter as a tool within the revenue growth management toolbox.
Cowboy Cut is competitively priced and allows the company to build on Marlboro's heritage during the country's 250th anniversary.
PM USA uses data-driven total portfolio approach to meet a broad set of consumer needs across premium and discount segments.
The company is making significant progress on resolving IP issues related to e-vapor products and feels good about bringing that product back to the marketplace at the appropriate time.
Regulatory and Compliance Environment
On! PLUS is supported by marketing with safeguards to limit reach to underage audiences and with a strong focus on regulatory compliance.
The FDA is reviewing applications for on! PLUS under its pilot program, with the company believing the science and evidence supporting all applications is compelling and provides a basis for FDA authorization within the 180-day statutory timeline.
Federal agencies worked alongside local law enforcement to combat illicit products, including a large-scale enforcement action in Northern Virginia supported by the Drug Enforcement Administration.
In states where product directories are in place and properly enforced, evidence shows these frameworks are helping to reduce the presence of illicit products in track channels.
A more efficient and predictable authorization process is needed to support reasonable, responsible innovation and establish a compliant legal marketplace of e-vapor products.
USSTC was the only smokeless company to have signed the master settlement agreement, which prevents the company from using tobacco brands in products that do not contain tobacco.
Financial Guidance and Outlook
2026 full year adjusted diluted EPS guidance is reaffirmed in a range of $5.56 to $5.72, representing a growth rate of 2.5% to 5.5% from a base of $5.42 in 2025.
As a result of strong first quarter performance, 2026 adjusted diluted EPS growth is now expected to be more balanced between the first half and the second half of the year.
The reaffirmed guidance range contemplates the impact of moderated e-vapor industry growth on combustible and e-vapor product volumes, and increased macroeconomic uncertainty facing adult nicotine consumers.
Leadership Transition
This was the final earnings call for CEO William F. Gifford, Jr., who expressed confidence in the leadership team and strategy in place going forward.
